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Abstract  44 
Recent advances in epigenetic research have enabled the development of epigenetic clocks 45 
which have greatly enhanced our ability to investigate molecular processes that contribute to 46 
aging and age-related disease. These biomarkers, offer the potential to measure the effect of 47 
environmental exposures linked to dynamic changes in DNA methylation, including 48 
nutrients, as factors in age-related disease. They also offer a compelling insight into how 49 
imbalances in the supply of nutrients, particularly B-vitamins, or polymorphisms in 50 
regulatory enzymes involved in one-carbon metabolism, the key pathway that supplies 51 
methyl groups for epigenetic reactions, may influence epigenetic age and interindividual 52 
disease susceptibility. 53 
Evidence from recent studies is critically reviewed, focusing on the significant contribution 54 
of the epigenetic clock to nutritional epigenomics and its impact on health outcomes and age-55 
related disease. Further longitudinal studies and randomized nutritional interventions are 56 
required to advance the field. 57 
Key words: Aging, B-vitamins, diet, DNA methylation, epigenetic age, epigenetic age 58 
acceleration, epigenetic clock, one-carbon metabolism  59 
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1.0 Introduction 66 
Epigenetic regulation has been identified as a key factor in aging (1) and is linked with diet, 67 
metabolism and disease (2,3). During the last decade, novel epigenetic clock models to 68 
identify DNA methylation signatures that accurately predict chronological age, disease and 69 
mortality, have also provided a measure of epigenetic or biological age. Epigenetic clocks 70 
offer immense potential to improve our understanding of the significant current global 71 
challenge of the disparity between the lengthening of average lifespan (4) which has not been 72 
matched by similar improvements in healthspan with relatively static rates of age-related 73 
disease (5). During the last decade, the application of epigenetic clock models to data 74 
generated by epigenome-wide association studies (EWAS) studies focused on dietary intakes 75 
and nutritional intervention is helping to uncover dietary determinants of healthy aging.  76 
Maintaining optimal nutritional status will have an important contribution to improving 77 
health outcomes with respect to age-related disease and healthspan. Several dietary factors 78 
are emerging as key modifiers of biological age and epigenetic clock models are helping to 79 
unravel the complex interplay of diet and age-related disease. Folate and related B-vitamins, 80 
essential cofactors in one-carbon metabolism, the main metabolic pathway for generating 81 
methyl groups for DNA methylation (6), are emerging as factors which can modify 82 
epigenetic age. Perturbations to DNA methylation owing to imbalances in the supply of B-83 
vitamins, or to polymorphisms or interactions between the various regulating enzymes could 84 
lead to aberrant DNA methylation and subsequently influence epigenetic age and disease 85 
susceptibility (7).  86 
Suboptimal B-vitamin status is associated with accelerated aging of the brain, declining 87 
cognitive function and cardiovascular disease, indicating that B-vitamins may play protective 88 
roles in age-related disease (8–10). High prevalence of low dietary intakes for B-vitamins 89 
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(i.e., below the estimated average requirement, EAR), including folate (29%–35%), vitamin 90 
B6 (24%–31%) and riboflavin (31%–41%) have been reported in older adults (11). More 91 
recent estimates from older adults (n 5290; ≥50 years) from the Irish Longitudinal Study on 92 
Ageing (TILDA) (Wave 1) and (n = 5186) from the Trinity Ulster Department of Agriculture 93 
(TUDA) study reported the prevalence of deficient or low B12 status (<185 pmol/l) as 12 % 94 
and 11.8% respectively, while the prevalence of deficient/low folate status was up to 15% 95 
(12,13).   96 
Application of epigenetic clock models to epigenomic data from dietary interventions or 97 
longitudinal studies of dietary intake offer immense potential for elucidating how nutrition 98 
can modulate age-related disease processes and improve health outcomes. As the volume of 99 
studies investigating the effect of nutrients, in particular B-vitamins, on DNA methylation in 100 
health and disease begin to increase, understanding the essential role of these nutrients in 101 
modulating DNA methylation age and age acceleration are critical.  102 
The aim of this literature review was to address this gap by providing a critical overview of 103 
recent studies using the epigenetic clock to predict biological age and age-related disease and 104 
the application of nutrition in modifying these parameters. Further longitudinal studies and 105 
randomized nutritional interventions are required. Additionally, challenges with methodology 106 
are highlighted and opportunities presented for researchers to consider for advancement of 107 
the field of nutritional epigenomics and age-related disease. 108 
 109 
2.0 Literature search strategy 110 
The literature search for this review was conducted by searching the Medline (via OvidSP) 111 
database and PubMed for articles published in English only and limited to human studies. Both 112 
medical subject headings and keywords were used in the search to identify articles with 113 
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relevant information on ageing, DNA methylation clock, diet and vitamins. This was 114 
subsequently followed by forward citation searching or ‘snowballing’ whereby relevant 115 
references were identified from key articles, followed up and repeating the process with each 116 
article used to obtain more literature.  117 
Medical subject headlines included: exp DNA Methylation/, exp Dietary Supplements/, exp 118 
Micronutrients/, Vitamins/, Vitamin B Complex/, Food, Fortified/, genome-wide 119 
methylation.mp. or Methylation/, Aging/ or Biological Clocks/ or Epigenetic clock.mp. or 120 
DNA Methylation/. The keywords used were: (diet or nutrient or cobalamin or folate or 121 
methionine or betaine or choline or riboflavin or "vitamin b2" or "vitamin b12") or 122 
(“methylation clock” or 450K or Methyl450 or Methylation450 or beadchip or "bead chip" or 123 
800k or epic or EWAS or genome-wide or genomewide or epigenome-wide or 124 
epigenomewide). Finally, only those articles with emphasis on vitamins, diet, micronutrients 125 
and methylation clocks were selected, and the relevant data was extracted for the review. 126 
 127 
3.0 DNA methylation and one-carbon metabolism 128 
3.1 DNA methylation 129 
DNA methylation is widely regarded as the most stable epigenetic mark involved in 130 
establishing patterns of gene expression and phenotype (14). It usually involves the covalent 131 
binding of methyl groups to the 5’position of a cytosine (5C) to form 5’-methylcytosine 132 
(5mC) and occurs within CpG dinucleotide sequences (15). DNA methylation may also occur 133 
at non-CpG sites, such as CpA, CpT, and CpC; however the functions and mechanisms of 134 
such methylation and implications for gene expression are currently not fully understood 135 
(16). This review, therefore, focuses on DNA methylation at 5mC. Methylation reactions are 136 
catalyzed by a family of DNA methyltransferases (DNMTs) which transfer a methyl group 137 
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from S-adenosylmethionine (SAM) (Figure 1). Removal of DNA methylation can occur via 138 
passive (failure to maintain methylation following replication) or active mechanisms. Active 139 
demethylation is carried out by the ten-eleven translocation methylcytosine dioxygenase 140 
enzymes (TETs) recently reviewed in (17) to produce 5mC derivatives, 5’-141 
hydroxymethylcytosine (5hmC), 5’-formylcytosine (5fC) and 5’-carboxylcytosine (5caC). 142 
Additionally, the 5caC is then removed through the action of base excision repair enzyme 143 
thymine DNA glycosylase (TDG) (18) (Figure 1).  144 
DNA methylation has differing functions, depending on its location within the genome. It is 145 
usually associated with transcriptional gene repression at CpG rich promoters; however, a 146 
mechanistic link between gene body methylation and active transcription is also suggested by 147 
enrichment of 5mC within gene bodies of transcribed genes (19). CpG sites dispersed 148 
throughout the genome are usually methylated (20,21), unlike CpGs lying within distinct, 149 
CG-rich CpG islands (CGIs), often found in the promoters of housekeeping genes (22),  150 
which are mostly unmethylated (20,21). In the regions immediately neighboring CpG islands, 151 
CpG shores (up to 2 kb from CGI), and CpG shelves (2-4 kb from CGI), display higher levels 152 
of methylation, with variations at these locations having a stronger impact on gene expression 153 
than the CpG island and may account for tissue-specific expression and disease variability 154 
(23,24). Additionally, methylation occurring at other genomic regions including, transcription 155 
start sites (TSS) and intergenic regions and has also been shown to influence transcription 156 
and gene expression (25,26).  157 
DNA methylation modifications are dynamic, extensively reprogrammed in early 158 
development, (27,28) and continue to a lesser, but nonetheless important extent throughout 159 
the lifespan, owing to the influence of various environmental conditions, particularly diet, 160 
which importantly contribute to both the aging process and disease susceptibility (29).  161 
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3.2 Influence of nutrients on DNA methylation 162 
One-carbon metabolism provides a direct link between nutrients, mainly folate and related B-163 
vitamins, and DNA methylation (Figure 1) and therefore has become of interest to 164 
investigate in epigenetic studies. The interconnected biochemical pathways generate methyl 165 
groups for the synthesis of purines and thymidine, and biological methylation reactions 166 
including DNA, RNA and histone methylation. Folate and related B-vitamins: vitamin B-12, 167 
vitamin B-6 and the largely overlooked vitamin B-2 (riboflavin), and other nutrients 168 
including methionine, choline and betaine provide substrates and cofactors to help the 169 
efficient functioning of the system. Folate from the diet or in the synthetic form, folic acid is 170 
converted to 5-methyltetrahydrofolate (5-mTHF) and dihydrofolate (DHF) respectively and 171 
subsequently to tetrahydrofolate (THF) (30). Tetrahydrofolate is then converted to 5,10-172 
methylenetetrahydrofolate and subsequently to 5-mTHF by methylenetetrahydrofolate 173 
reductase (MTHFR) with vitamin B-2 (riboflavin) as a cofactor. 5-mTHF is then 174 
demethylated as the 1-carbon is donated for remethylation of homocysteine to methionine by 175 
methionine synthase (MTR) with vitamin B-12 as a cofactor (31). 5,10-176 
methylenetetrahydrofolate dehydrogenase (MTHFD1), catalyzes the conversion of 177 
tetrahydrofolate to 10-formyl, 5,10-methenyl and 5,10-methylene derivatives subsequently 178 
used as cofactors for de novo purine and pyrimidine synthesis (30,32). The choline-betaine 179 
pathway is a parallel pathway that involves a transfer of a methyl group from betaine to 180 
homocysteine, a B-6 dependent reaction, to produce dimethylglycine (DMG) and methionine. 181 
Methionine regenerated from homocysteine serves as a precursor for S-adenosylmethionine 182 
(SAM) and is then converted to S-adenosylhomocysteine (SAH) during the methyl transfer 183 
(33). The cellular potential for DNA methylation relies upon the relative amounts of the 184 
methyl donor SAM and its reaction product SAH (34). The effects of dietary intake or 185 
supplementation with B-vitamins has been shown in a limited number of studies to increase 186 
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SAM concentrations (35,36). Supplementation with riboflavin (1.6 mg/d for 16 weeks) and 187 
folic acid (5 mg/d for 8 weeks) increased means plasma SAM levels in adults with the 188 
MTHFR 677TT genotype (35,36). It has been postulated that the higher the SAM:SAH ratio, 189 
the greater the methylation potential of the cell, although conflicting evidence suggests that 190 
DNA methylation may proceed without changes in the ratio (37,38). Further studies are 191 
required to clarify the effect of dietary molecules on SAM concentrations and DNA 192 
methylation. 193 
Perturbations in one-carbon metabolism may occur through low intake of nutrients involved 194 
in one-carbon metabolism (7), malabsorption of nutrients via disease or cellular conditions, 195 
interactions in regulatory enzymes in one-carbon metabolism pathways as well as common 196 
polymorphisms within genes that code for enzymes important for the normal functioning of 197 
one-carbon metabolism (2,39). Apart from significant disruption to one-carbon metabolism, 198 
these perturbations may have functional implications on downstream biological processes 199 
including DNA methylation and synthesis.  200 
3.3 Common polymorphisms in genes involved in one-carbon metabolism 201 
Common polymorphisms in genes involved in one-carbon metabolism can influence enzyme 202 
activities, and subsequently metabolite and substrate concentrations in the pathway. The 203 
MTHFR C677T polymorphism results in reduced MTHFR enzyme activity in individuals 204 
with the 677TT genotype which encodes a thermolabile enzyme (40). Elevated plasma 205 
homocysteine indicates perturbed one-carbon metabolism in 677TT individuals, and it is 206 
plausible that altered concentrations of SAM and therefore availability of methyl donors for 207 
methylation reactions may ensue. The well-established phenotype of elevated homocysteine 208 
is widely reported in different populations. A large-scale population-based study (n = 10,601) 209 
strong associations of MTHFR c665C>T polymorphism with blood concentrations of total 210 
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plasma homocysteine and serum folate (41). The 665TT genotype was associated with a 211 
higher concentration of homocysteine and lower concentration of folate than the 665CC 212 
genotype, with the CT genotype having intermediate concentrations. Riboflavin 213 
supplementation in a randomized controlled trial of adults reduced plasma homocysteine 214 
specifically in 677TT individuals (42) indicating that riboflavin may stabilize the 215 
thermolabile enzyme and restore MTHFR activity, and thus is an very interesting nutrient for 216 
future epigenetic investigations. A recent study by our group using evidence from 217 
randomized controlled trials showed that supplementation with riboflavin resulted in 218 
decreased global and MTHFR north shore methylation in adults with the MTHFR 677TT 219 
genotype (43).  220 
Polymorphisms can also act as strong cis-regulatory elements (cis-meQTL; cis-methylation 221 
quantitative trait loci) to regulate the methylation levels of their own gene promoter or trans-222 
regulatory elements (trans-meQTL) regulating methylation of other genes. For example, 57 223 
CpGs were differentially methylated depending on genotype of 6 one-carbon metabolism 224 
genes (FTHFD, MTHFD1, MTHFR, MTR, MTRR and TYMS; P < 0.5 x 10
-5). The MTHFR 225 
rs1801133 SNP (responsible for the C677T polymorphism) was shown to act as a trans-226 
meQTL regulatory element in breast tissue associated with lower methylation of 5 CpGs 227 
(CLEC17A, DLX6AS, cg13811423, cg14118666, and cg181152144; average OR = 0.15; 228 
average 95% CI, 0.05–0.42) (44). The MTHFR promoter itself is also a target for trans-229 
meQTL regulatory elements such as the DNMT3B -149C>T polymorphism. Increasing the 230 
number of T alleles at this position significantly increased MTHFR methylation with the 231 
DNMT3B -149CC genotype having significantly lower levels of MTHFR methylation than 232 
the CT genotype, which in turn had significantly lower levels of methylation than subjects 233 
with the TT genotype (45).   234 
 235 
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3.4 Role of DNA methylation and diet in aging and disease 236 
The aging process is complex and involves numerous changes at both the molecular and 237 
cellular level, including epigenetic remodeling of the DNA methylome (46,47). DNA 238 
methylation patterns, established early in development, progressively diverge throughout the 239 
life course, with age-associated DNA methylation features identified by middle-age at a large 240 
number of CpG sites continuing to undergo changes into old age (48). Changes in DNA 241 
methylation associated with age have been observed in many cross-sectional studies; 242 
however longitudinal evidence which is not confounded by interindividual differences is 243 
more limited. In such studies, longitudinal analysis of a cohort of elderly twin pairs identified 244 
2284 CpG sites where DNA methylation levels changed over a 10-year follow-up period 245 
(49). A 20 year study of 385 older Swedish twins also identified 1316 longitudinal age-246 
associated methylation sites which were validated in two independent cohorts (50). While it 247 
is now well accepted that epigenetic alterations are hallmarks of ageing, understanding the 248 
causality between these epigenetic changes and the aging process has not been fully 249 
elucidated and is still an active area of investigation (51). Multiple studies have reported not 250 
only significant associations between aging and DNA methylation (52,53) but also 251 
associations between age-related diseases and epigenetic alterations. The processes that drive 252 
the changes in the aging methylome, and subsequent implications for disease and mortality 253 
risk are currently not well understood, however, several potential mechanisms have been 254 
proposed. These include effects on immunity and inflammation, while environmental factors, 255 
such as diet, stress, physical activity, socioeconomic status and smoking (52,54–56) could 256 
impact these mechanisms or act directly to age the methylome. Aging-associated immune-257 
system impairments are mediated via changes in DNA methylation in nonagenarians. In a 258 
cross‐sectional analysis of 4,173 postmenopausal females, age-related changes in immune 259 
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functioning and inflammation were also shown to contribute to increased susceptibility to a 260 
wide range of diseases (57,58).   261 
Dietary factors, particularly B-vitamins, may modulate DNA methylation and thereby 262 
influence age-related disease. In studies investigating B-vitamins and DNA methylation in 263 
disease, Fiorito and colleagues (59) reported that DNA methylation of specific genes (TCN2, 264 
CBS, PON1, AMT) involved in one-carbon metabolism and homocysteine metabolic 265 
pathways could mediate the CVD risk conferred by low dietary intake of B-vitamins. 266 
Furthermore, using highly robust and comprehensive microarray methods, several large 267 
epigenome-wide methylation studies (EWAS) have shown that supplementation with B-268 
vitamins predominantly folate and vitamin B-12 or dietary intake of these nutrients modulate 269 
DNA methylation at the genome-wide level in older adults (Table 1), highlighting key targets 270 
that could be further explored in age-related nutritional epigenomics studies (60,61). 271 
Riboflavin has not been as widely studied as other B-vitamins with only one epigenome-wide 272 
study reporting the effects of variability in dietary intake on DNA methylation. Low dietary 273 
intake of riboflavin was associated with higher methylation at one CpG (cg21230392; P = 274 
5E-8) in a study involving participants from the Melbourne Collaborative Cohort Study 275 
(MCCS) (62). Additionally, supplementation with flavanols and polyphenols may affect the 276 
activity of enzymes including DNMTs and significantly impact methylation (63). For 277 
example, (–)-epigallocatechin-3-gallate (EGCG), a key polyphenol in tea inhibits DNMT 278 
activity resulting in demethylation and reactivation of methylation-silenced genes in cancer 279 
cells. Further evidence from randomized control trials of nutrients, such as riboflavin 280 
supplementation could elucidate how individual nutrients influence the epigenome and age-281 
related disease.   282 
 283 
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4.0 Epigenetic Clocks 284 
4.1 Epigenetic drift versus epigenetic clock 285 
Studies of monozygotic (MZ) twins have showed that although twins are epigenetically 286 
indistinguishable during the early years of life, older monozygotic twins exhibited remarkable 287 
differences in their epigenome, indicating that patterns of epigenetic modifications in MZ 288 
twin pairs diverge as they become older (64). Entropic decay of DNA methylation during 289 
aging is observed with twin studies also revealing that repeat sequences generally become 290 
more hypomethylated during aging (65,66) while methylation increases are noted at 291 
individual regulatory locus-specific regions (67) (Figure 2). Tissue-dependent DNA 292 
methylation variation may explain why particular organs and tissues are susceptible to 293 
different diseases (68). Many methylation changes leading to interindividual divergence 294 
occur stochastically during aging and are known as “epigenetic drift”. Specific CpG sites 295 
have been identified to undergo reproducible methylation changes across individuals with age 296 
allowing their utilization in epigenetic clock algorithms (69) which can be used to accurately 297 
predict chronological age and estimate biological age (Figure 2).  298 
4.2 Epigenetic clocks and age acceleration 299 
Chronological age as a predictor of disease risk and mortality is suboptimal as individuals 300 
with the same chronological age may exhibit different susceptibility to age-related diseases 301 
owing to differences in underlying biological aging processes (70). This has led to the advent 302 
of several DNA methylation-based models of biological aging known as epigenetic clocks 303 
(Table 2). Each clock is derived by a linear regression algorithm that trains against the 304 
chronological age of sample donors and selects a set of CpGs, determining the weighted 305 
contribution of each CpG in the set to produce a DNA methylation age (DNAm Age) that 306 
correlates accurately with chronological age. The first of these to have a major impact was 307 
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the Horvath clock (69) which analyses methylation at 353 CpGs and was developed using a 308 
panel of 51 different non-cancerous tissues and cell lines, leading to it being known as a pan-309 
tissue clock. This feature has enabled accurate predictions of DNAm Age across 310 
heterogeneous tissues and cell types. Owing to the wide age range of individuals from which 311 
the samples were derived, the Horvath clock is also known as a life course clock and is 312 
applicable to analysis of epigenetic age in children and peri-natal samples (71). The Hannum 313 
methylation clock (56) was derived from analysis of whole blood in 482 individuals of either 314 
Caucasian or Hispanic ethnicity using 71 CpGs to provide superior accuracy in age 315 
determination. A recent meta-analysis of over 41,607 participants indicated that each 5-year 316 
increase in DNA methylation age, estimated using either the Horvath or Hannum clocks, was 317 
associated with an 8 to 15% increased risk of mortality (72).  318 
When biological age (DNAm Age) exceeds chronological age, age acceleration (AgeAccel) 319 
is said to be experienced and this measure is perhaps of most interest to scientists and 320 
clinicians studying aging and disease. AgeAccel is defined as the residual from regressing 321 
DNAm Age on chronological age, where a positive value indicates that epigenetic age is 322 
greater than expected. Horvath further characterized epigenetic age acceleration as either 323 
intrinsic (IEAA) or extrinsic (EEAA) epigenetic age acceleration. IEAA is a measure of age 324 
acceleration that is independent of age-related changes in the cellular composition of blood 325 
whereas EEAA captures the age-related-functional decline of the immune system and 326 
accounts for changes in blood cell composition such as the decrease of naive CD8+ T cells 327 
and the increase in memory or exhausted CD8+ T cells (73). 328 
To investigate biological age more extensively and discriminate morbidity and mortality 329 
more accurately among individuals of the same chronological age, recently developed clocks 330 
have been trained on age-related and disease phenotypes in combination with chronological 331 
age. Two of the most robust are the DNAm Phenotypic Age predictor (DNAm PhenoAge) 332 
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(74) and the DNAm-based biomarker of mortality GrimAge (DNAm GrimAge) (75). The 333 
PhenoAge clock calculates phenotypic age in a two-step process. Initially, 42 clinical blood 334 
biomarkers that predict mortality in the third National Health and Nutrition Examination 335 
Survey (NHANES III) were used to derive an estimate of phenotypic age. Subsequently, 336 
refinement to select nine of these biomarkers plus chronological age were used independently 337 
of DNA methylation to predict phenotypic age. In the final model, a phenotypic age was 338 
calculated in the independent Invecchiare in Chianti (InCHIANTI) cohort and a DNA 339 
methylation proxy of phenotypic age (DNAm PhenoAge) and age acceleration 340 
(AgeAccelPheno) were derived based on a set of 513 CpGs. The Horvath and Hannum clocks 341 
are not influenced by smoking status; however, the DNAm PhenoAge clock includes this 342 
disease-related factor associated with DNA methylation changes. The PhenoAge clock was 343 
found to outperform the Horvath and Hannum epigenetic age measures with respect to a 344 
variety of aging outcomes, including all-cause mortality, cancers, healthspan, physical 345 
functioning and Alzheimer’s disease (74). The most recent of these biological clocks, DNAm 346 
GrimAge, was trained using the Framingham Heart Study (74) and tracks methylation of 347 
CpGs of blood-based protein biomarkers that are known to be associated with health such as 348 
plasminogen activation inhibitor 1 (PAI-1), and growth differentiation factor 15 (GDF15), as 349 
well as a more sensitive measure of CpGs associated with smoking through an estimate of 350 
“pack years”. Incorporation of valuable information from these loci has resulted in 351 
improvements in accuracy of age acceleration (GrimAgeAccel) which has been shown to be 352 
18% more accurate than chronological age and 14% more accurate than previously described 353 
clocks in predictions of time to disease (42). DNA methylation age is currently one of the 354 
most accurate measures of aging and life expectancy in a range of traditional measures such 355 
as telomere length, proteomic, transcriptomic and metabolomic biomarkers in accurately 356 
estimating biological age (76). 357 
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The CpGs which are included in the clock algorithms are widely distributed across the 358 
genome and do not appear to be clustered in or near any particular genomic feature or any 359 
particular regulatory region. The methylation clocks and associated challenges have been 360 
extensively reviewed recently (77,78). It is important to note that, although these clocks are 361 
highly correlated with chronological age, they were constructed using different algorithms 362 
which may influence their prediction of disease and health outcomes; therefore careful 363 
consideration should be given to the most appropriate clock to utilize in any given study.  364 
Epigenetic clocks are not linear across the lifespan. Many of the current epigenetic clock 365 
studies have been conducted in adults, and as a result, many show impressive accuracy across 366 
most tissues during middle age (79). In later life, however, chronological age increases at a 367 
faster rate than epigenetic age, particularly in the Horvath and Hannum clocks (80). A non-368 
linear pattern is also observed in the clock during childhood (71) and teenage years, due to a 369 
greater rate of DNA methylation change in children than adults (81). The Horvath clock has 370 
been adjusted to include a log linear transformation for data points from younger individuals 371 
and a new clock trained on pediatric buccal swabs has increased predictive power in samples 372 
from children (82).  Furthermore, as none of the clocks are well-suited to estimating 373 
gestational age, the recent development of a placenta clock can be used to closely track fetal 374 
age during development (83). 375 
4.3 Epigenetic age, age acceleration and health outcomes 376 
Epigenetic age and age acceleration are strongly linked to all-cause mortality, higher cancer 377 
and CVD mortality and are associated with important inflammatory biomarkers including C-378 
reactive protein, interleukin 6 and monocyte chemotactic protein (84,85). Table 3 provides 379 
an overview of age-related conditions, DNA methylation age and age acceleration measured 380 
by the four different clocks. Although the list is not comprehensive, it is indicative of the 381 
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broad range of age-related diseases associated with altered epigenetic age. Of particular note, 382 
cardiovascular disease and related measures such as blood pressure have emerged as age-383 
related conditions that are robustly correlated with methylation in a range of epigenetic 384 
clocks. Accelerated PhenoAge is associated with higher risk of coronary heart disease (β= 385 
0.016 – 0.073; Meta P = 3.35E-11) and both higher EEAA (r = 0.07, P = 4E-6) and 386 
AgeAccelPheno (r = 0.08, P = 1E-6) are associated with elevated systolic blood pressure 387 
(58,74). GrimAgeAccel also gives the most accurate predictions of time-to-coronary heart 388 
disease (HR = 1.07, P = 6.2E-24) and time-to-cancer (HR = 1.07, P = 1.3E-12) and also 389 
demonstrates a strong association with hypertension (OR = 1.04, P = 5.1E-13) (75).  390 
4.4 Epigenetic Age, age acceleration and dietary factors 391 
The influence of diet in the etiology of many age-related diseases is well established and the 392 
advent of epigenetic clocks has brought a novel approach to confirm diet as an important 393 
health factor (75). Epigenetic age, and age acceleration are linked to a variety of dietary 394 
factors such as fish, fruit and vegetable intakes indicating that a healthy diet and lifestyle 395 
could positively influence epigenetic age acceleration (Table 4). For example, a recent study 396 
highlighted that omega-3 polyunsaturated fatty acid (PUFA) supplementation and vegetable 397 
consumption appear to be associated with lower GrimAgeAccel (41); however as this 398 
association was made from an observational study, further validation from prospective 399 
clinical trials is required. Application of epigenetic clock models to epigenomic data from 400 
longitudinal studies or dietary interventions to measure biological age and age acceleration 401 
offer immense potential for elucidating how dietary interventions can modulate the aging and 402 
disease processes. 403 
It also appears that sex and genotype may play a role in modulating epigenetic age 404 
acceleration in response to dietary factors. The epigenetic age acceleration lowering of 405 
18 
 
omega-3 PUFAs also appears to be more pronounced in males (GrimAgeAccel: r = -0.08, P = 406 
0.012) than in females (r = -0.05, P = 0.07). Furthermore, epigenome-wide methylation 407 
results from the B-PROOF study, intervening with daily folic acid and vitamin B-12 408 
supplements  in a robust two year randomized controlled trial (RCT) (86), were inputted into 409 
the online DNA methylation age calculator to demonstrate that AgeAccel is reduced in 410 
women with the MTHFR 677CC but not the 677TT genotype (87). Careful consideration of 411 
sex and genotype must therefore be undertaken in the design of epigenetic studies. 412 
In the first and currently only study to indicate the possibility of reversal of biological age, 413 
the TRIIM trial used a cocktail of drugs comprising recombinant human growth hormone 414 
(rhGH) to prevent or reverse signs of immunosenescence in a one-year pilot trial of 51-65 415 
year old healthy men showed a regression of epigenetic age of -2.5 years on average (70). 416 
Although the trial was small (n = 9) and, crucially, did not include a control arm, suggestions 417 
of biological age reversal were found in all four robust methylation clocks available, and in 418 
each individual. This study was the first to indicate that potential regression of multiple 419 
aspects and biomarkers of aging, including immune function, was possible in humans (70).   420 
While itself not a dietary factor, it is interesting to note that growth hormone, the supplement 421 
chosen in the aforementioned epigenetic age reversal trial, has been noted to perturb mRNA 422 
and protein levels of DNMT1 (88) and it has been postulated that the age-related dysfunction 423 
of growth hormone may play a role in the reduction of DNMTs in aging (78). Further roles 424 
for age-related dietary factors such as S-adenosylmethionine (SAM) and α-ketoglutarate 425 
(AKG) have been suggested to alter activity of DNMTs and their counterpart TET enzymes 426 
during the aging process. The observed age-associated decline in genome-wide methylation 427 
may be exacerbated by an observed age-related decline of the essential DNMT substrate, 428 
SAM (89,90) which could result in demethylation of some clock CpGs. Indeed DNMT 429 
enzymes also decrease with age in some tissues (88,91). Furthermore, the hypermethylation 430 
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of specific loci during aging may be attributable to the decline in AKG and ensuing 431 
reductions in TET enzyme activity (78). AKG declines with age (92), reducing its availability 432 
as a cofactor for TETs in active demethylation reactions and ensuing hypermethylation of 433 
locus-specific regions (93). In support of this theory, AKG has recently been demonstrated to 434 
be a rate‐limiting factor controlling DNA demethylation in aging mice (92). This remains 435 
speculative, however, because no studies to date have investigated the specific effects of 436 
these nutrients on enzyme activity or epigenetic aging. 437 
Despite their obvious strengths, DNA methylation-based clocks are unlikely to replace 438 
existing clinical biomarkers and measurements such as blood pressure, walking speed, grip 439 
strength which are cost effective and easy to perform. The cost of measuring DNA 440 
methylation age prevents the standard adoption of this method, at least until it becomes more 441 
affordable. In fact, GrimAge is 61% more accurate than chronological age and 46% more 442 
accurate than previously reported epigenetic clocks in predicting time to coronary heart 443 
disease. However, despite this significant advancement, neither chronological nor GrimAge  444 
are entirely accurate estimators of coronary heart disease and further work is required to 445 
determine their role as predictors of cardiovascular and other disease outcomes.    446 
 447 
5.0 Methodological aspects of studies investigating DNA methylation and diet 448 
Despite the growing interest in the role of diet in influencing DNA methylation and age-449 
related disease, most previous studies in humans were not designed with DNA methylation as 450 
the primary outcome, resulting in limited data to provide concrete evidence linking the diet to 451 
DNA methylation. The methodological aspects of appropriate study design for the 452 
investigation of diet and DNA methylation will be discussed further. 453 
 454 
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5.1 Study design and population 455 
The study design utilized as well as dietary or biochemical data collected are critical when 456 
investigating the link between nutrient intake or status and DNA methylation. The majority of 457 
studies so far are observational and have provided inconsistent evidence for the role of 458 
dietary factors, especially B-vitamins, in modulating DNA methylation, perhaps owing to 459 
inconsistencies in study design and choice of assay (94). While observational studies offer the 460 
advantage of providing comprehensive data with large sample sizes and highlight 461 
associations between nutrients and DNA methylation, they are unable to provide clarity with 462 
respect to dietary causality. Randomized controlled trials represent a robust study design for 463 
establishing the effects of B-vitamins on DNA methylation; however studies of this nature 464 
are lacking. Although no study on its own can prove causality, randomization in RCTs 465 
reduces bias and provides a rigorous tool to examine cause-effect relationships between an 466 
intervention and an outcome (95). Additionally, apart from establishing the biological roles of 467 
B-vitamins in modulating DNA methylation, there is a need for RCTs to further incorporate 468 
dose-response design in order to determine the optimum doses of B-vitamins required to 469 
modulate DNA methylation. Longitudinal studies which assess methylation in individuals at 470 
several time points, and thereby reduce noise in the methylation signal owing to 471 
interindividual variation, is particularly useful in helping to elucidate the role of diet and 472 
methylation in disease. Furthermore, the majority of existing studies have employed food 473 
frequency questionnaires in estimating dietary intake, yielding only semi-quantitative data, 474 
prone to measurement errors which may not accurately reflect status, resulting in 475 
misclassification which can compromise the ability to detect statistically significant 476 
associations (96). Importantly, biochemical biomarker concentrations of status provide more 477 
reliable indicators than dietary intake to investigate the relationship between B-vitamins and 478 
DNA methylation. 479 
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5.2 Novel Approaches for DNA methylation analyses in nutrition studies 480 
Methods to examine DNA methylation have evolved over the years and have become more 481 
sophisticated.  While commonly used methods including high performance liquid 482 
chromatography-ultraviolet (HPLC-UV), liquid chromatography coupled with tandem mass 483 
spectrometry (LC-MS/MS), methyl acceptance assay and pyrosequencing are still useful in 484 
analyses of DNA methylation, novel technologies such as the Infinium 485 
HumanMethylation450K BeadChip array (450K) or the Infinium MethylationEPIC BeadChip 486 
(850K) microarray provide higher resolution for analyzing DNA methylation on a genome-487 
wide scale (97,98). Although not offering as much genome coverage as whole genome 488 
bisulfite sequencing (WGBS), the Illumina arrays analyze a significant proportion of total 489 
sites for DNA methylation at 853,307 CpG sites (EPIC/850K) and 485,764 CpG sites (450K) 490 
across the human genome. The CpG sites interrogated by the 850K array include 439,562 491 
CpGs out of 482,421 CpGs included in the 450K microarray and an additional 413,745 new 492 
CpG sites that were not included in the 450K microarray. The EPIC array provides a highly 493 
reliable genomic platform for studying DNA methylation patterns across the genome 494 
especially in underexplored territories including enhancer sequences (99). Furthermore, in 495 
comparison to WGBS, Illumina microarrays provide good value for money in terms of 496 
desired coverage, resolution and number of samples that can be analyzed, providing large 497 
amounts of high-quality data which can be easily input into epigenetic clock algorithms. 498 
Advantages of using these approaches include the production of large datasets which can be 499 
analyzed by streamlined analytical pipelines, providing important information on the 500 
epigenome-wide landscape. Several sophisticated computational tools and software are 501 
available for the analysis and interpretation of large EWAS datasets. The relevant concepts, 502 
computational methods and software for the analysis and interpretation of large DNA 503 
methylation data as well as statistical considerations have been thoroughly reviewed by Bock, 504 
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Teschendorff and colleagues (100,101). These statistical approaches allow for computation of 505 
epigenetic age, and are able to control for false discovery rates and adjust for cell and tissue 506 
variation, which are all major sources of confounding in DNA methylation studies. Some of 507 
the popular and widely used software for processing and analysis of bisulfite microarray data 508 
in particular include minfi (102), RnBeads (103), The Chip Analysis Methylation Pipeline 509 
(ChAMP) (104), and methylumi (105). Furthermore, other software packages such as 510 
dmrFinder (106), DMRcate (14) and IMA (107) are available for the identification of DMRs. 511 
New platforms such as CandiMeth (https://github.com/sjthursby/CandiMeth) are also making 512 
it easier for those with little bioinformatics experience to look at methylation across the 513 
genome in samples for which array data is available.   514 
6.0 Conclusion  515 
Nutritional epigenomics has highlighted diet as a critical factor with the potential to influence 516 
both healthspan and lifespan. Novel insights into how perturbations in one-carbon 517 
metabolism influence DNA methylation and data from epigenome-wide studies of nutrition 518 
interventions offer promising insights to understanding how diet impacts the methylome 519 
during healthy aging and disease. Epigenetic clocks provide an exciting additional insight 520 
into how preventive and treatment strategies may increase the healthspan of an aging global 521 
population. Despite the heightened research interests in nutritional epigenomics, the field is 522 
still beset with several methodological challenges, which greatly impact the quality of 523 
evidence currently available. The population under study must be extensively characterized to 524 
identify and exclude possible confounding factors. Robust study designs, which utilize 525 
randomization and measure appropriate biomarkers, are required to clarify the factors 526 
underlying epigenetic aging. Replication and validation of findings in multiple independent 527 
cohorts are essential to reduce reporting of false positive findings. Epigenetic clocks 528 
described here have sampled individuals from a wide spectrum of ages. A DNA methylation 529 
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clock which focuses on older people or those with specific diseases could help to more 530 
accurately predict age-related disease and help to identify factors which delay or prevent this 531 
progression. Improvements in estimating time to disease have been made in the latest 532 
GrimAge clock, which is significantly more predictive than chronological age in estimating 533 
time to various diseases; however much additional research is required to advance our 534 
knowledge and understanding in relation to coronary heart disease. Longitudinal studies offer 535 
the important advantage of tracking individuals over extended periods to enable the 536 
identification of factors which influence the diagnosis and treatment of disease, making these 537 
studies particularly valuable for clarifying whether observed changes in DNA methylation are 538 
a result of disease or have a causal role. A better understanding of the DNA methylome 539 
during aging will offer the opportunity to promote healthy aging and identify nutritional 540 
interventions which delay or prevent age-related disease in order to influence public health 541 
outcomes and policies. 542 
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Figure Legends 
Figure 1: Brief Summary of One-carbon Metabolism and DNA methylation.  
Abbreviations: BER, base excision repair enzymes; BHMT, betaine-homocysteine S-
methyltransferase DHF, dihydrofolate; DMG, dimethylglycine; DNMT, DNA 
methyltransferase; MTHFR, methylenetetrahydrofolate reductase; MTR, methionine 
synthase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SHMT, serine 
hydroxymethyltransferase; TDG, thymine DNA glycosylase; TET, ten-eleven translocation 
methylcytosine dioxygenase enzymes;  THF, tetrahydrofolate. 
Figure 2: DNA methylation patterns of monozygotic twins diverge during aging.  
Despite early similarities, stochastic changes occur in the methylome of each twin, A and B 
during aging. Epigenetic drift results in age-related hypermethylation of CpG rich sequences 
such as CGI promoters, typically found in ubiquitously expressed house-keeping genes, 
which may be switched off as a result of aberrant age-related methylation. In contrast, highly 
methylated, transcriptionally repressed CpG poor promoters tend to become hypomethylated 
during aging, leading to aberrant gene expression. Tandem satellite repeat sequences in the 
telomere are also heavily methylated which may promote genome stability and inhibit 
recombination. Hypermethylated interspersed repeats such as LTRs, SINEs and LINEs tend 
to undergo generalized hypomethylation during aging. A selection of CpGs (*) undergo 
programed reproducible methylation changes across the population during aging and have 
been incorporated into epigenetic clock algorithms used to accurately predict epigenetic age. 
Each lollipop represents an individual CpG, arrows indicate transcription start sites, X 
indicates transcriptional repression. CGI, CpG island; LINE, long interspersed nuclear 
element; LTR, long terminal repeat; SINE, short interspersed nuclear element.  
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Table 1:   
Dietary influence on DNA methylation using the Illumina microarray platforms 
Study Study 
design 
Population  Sample 
size (n) 
Dietary factor Source of 
DNA 
Effect 
  
Randomized controlled trials and intervention studies 
Kok et al. 2015 (86) RCT B-vitamins for the 
Prevention of 
Osteoporotic Fractures 
(B-PROOF) study 
 87 Folic acid, vitamin-
B12 supplementation 
Buffy coat Differential methylation at 162 positions 
upon FA/vB-12 supplementation (1 
DMP, cg19380919 sig) in intervention 
compared to placebo.  
       6 DMRs differed significantly between 
intervention and placebo groups.  
Serum folate and vitamin B-12 
significantly related to DNA 
methylation of 173 and 425 regions 
respectively. 
Arpon et al. 
2016(108) 
Intervention 
study 
PREDIMED study  36 Mediterranean diet 
supplemented with 
extra virgin olive oil 
Peripheral 
blood cells 
Med Diet is associated with differential 
methylation of inflammation-related 
genes. 
  
Cross-sectional studies 
Chamberlain et al., 
2018 (62) 
Cross-
sectional 
Melbourne Collaborative 
Cohort Study (MCCS) 
 5186 Dietary intake of 
folate, riboflavin, 
vitamins B-6 and B-
Peripheral 
blood 
Low intake of riboflavin associated with 
higher methylation at CpG cg21230392 
(P = 5E-8).  
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12, methionine, 
choline, betaine 
Mandaviya et al., 
2019 (109) 
Cross-
sectional 
10 cohorts from Europe 
and United States  
 5841 Dietary intake of 
folate, vitamin B-12 
Leukocytes  6 DMPs and 73 DMRs negatively 
associated with folate intake. Intake of 
vitamin B-12 associated with 29 DMRs. 
Perrier et al., 2019 
(110) 
Cross-
sectional 
The European 
Prospective Investigation 
into Cancer & Nutrition 
(EPIC) study 
 450 Dietary intake of 
folate 
Buffy coat Dietary intake of folate associated with 
differential methylation at 24 regions 
(FDR, P < 0.05). 
DMP, differentially methylated position; DMR, differentially methylated region; FDR, false discovery rate. 
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Table 2.   
Key features of epigenetic DNA methylation clocks 
DNA 
methylation 
clock 
Number 
of  
CpGs 
Platform 
used in 
development 
Tissues 
used  
in training 
Training set Key Features 
Horvath (69) 353 27K & 450K Multiple 
tissues 
 (n = 51) 
Multiple studies,  
n = 7844, mean age 43 years 
Predicts methylation age across the lifespan  
     Can be applied to children and pre-natal samples 
     Provides estimates of both intrinsic and extrinsic epigenetic 
age 
     Estimations may be biased in older adults 
Hannum (56) 71 27K & 450K Blood Two cohorts,  
n = 656 (n1 = 482; n2 = 174), age range 
19-101 years 
Tailored to adult blood samples and may lead to biased 
estimates in children and in non-blood tissues 
     Age estimations may be confounded by age-related changes in 
blood composition 
     Provides a more accurate prediction of life expectancy than 
Horvath clock 
PhenoAge 
(74) 
 
513 27K, 450K & 
EPIC 
Blood 2 step process: 
i) Phenotypic age; NHANES-III, n = 
9926, age > 20 years 
Biomarker relates to numerous age-related diseases and 
disease phenotypes 
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    ii) Epigenetic marker of phenotypic 
age; InCHIANTI, n = 456, age range 
21-100 years 
Improved predictive power over previous Horvath & Hannum 
clocks 
     Incorporates nine age-related biochemical measures and 
smoking-related changes in DNA methylation 
     Captures organismal age and the functional state of organs and 
tissues 
     Estimations may be biased in children and in non-blood 
tissues 
GrimAge (75) 1030 450K & EPIC Blood Framingham Heart Study (FHS), n = 
2536 divided into:  
DNA methylation surrogates developed for seven plasma 
proteins plus smoking pack years  
    i) training set n = 1731 from 622 
pedigrees, mean age 66 years 
Currently best predictive epigenetic biomarker for lifespan 
and time to coronary heart disease (18% and 61%,) 
respectively more predictive than chronological age 
    ii) test set n = 625 from 266 pedigrees, 
mean age 67 years 
Highlights healthy diet and educational attainment as 
predictors of biological age   
Summary of the key features of the four current epigenetic clocks, including the number of CpGs included in algorithm, the platforms and tissues used in development and 
the tissues used in training. 27K, Infinium 27K BeadChip array; 450K, HumanMethylation450K BeadChip array; EPIC, Infinium MethylationEPIC BeadChip (850K) 
microarray.
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Table 3: 
Associations between epigenetic age and age-related conditions 
Study Study 
design 
Population  Sample 
size (n) 
Age estimator Source of 
DNA  
Age-related 
condition 
Association 
 
Cross-sectional studies 
Fiorito et al. 
2019 (54) 
Cross-
sectional 
17 cohorts from Europe, 
the United States and 
Australia 
16,245 Horvath EAA 
 
Blood Obesity Obesity (BMI ≥ 30) associated with higher 
EAA (β = 0.43, CI: 0.24; 0.61, P < 0.001). 
Fiorito et al. 
2019 (54) 
Cross-
sectional 
17 cohorts from Europe, 
the United States and 
Australia 
16,245 Hannum EAA Blood Obesity Obesity (BMI ≥ 30) associated with higher 
EAA (β = 0.20 CI: 0.05; 0.34, P < 0.05). 
Fiorito et al. 
2019 (54) 
Cross-
sectional 
17 cohorts from Europe, 
the United States and 
Australia 
16,245 Levine EAA Blood Obesity Obesity (BMI ≥ 30) associated with higher 
Levine EAA (β = 1.01 CI: 0.74; 1.28, P < 
0.001). 
Hillary et al., 
2019 (111) 
Cross-
sectional 
Lothian Birth Cohort 1936 709 DNAm 
GrimAge 
Whole 
blood  
Cognitive 
performance 
Higher DNAm GrimAge associated with lower 
cognitive ability (β = −0.18, P = 8E-6), brain 
vascular lesions in older age independent of 
early life cognitive ability. 
Irvin et al., 
2018 (84) 
Cross-
sectional 
Genetics of Lipid 
Lowering Drugs and diet 
Network (GOLDN) study 
830 Horvath EAA Blood Inflammatory 
markers 
EAA marginally associated with increased 
postprandial HDL (P = 0.05), increased 
postprandial total cholesterol (P = 0.06), and 
decreased soluble interleukin 2 receptor 
subunit alpha (P = 0.02).  
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Irvin et al., 
2018 (84) 
Cross-
sectional 
Genetics of Lipid 
Lowering Drugs and diet 
Network (GOLDN) study 
830 Hannum EAA  Blood Inflammatory 
markers 
EEAA inversely associated with fasting HDL 
(P = 0.02), positively associated with 
postprandial TG (P = 0.02), interleukin-6 (P = 
0.007), C-reactive protein (P = 0.0001), and 
tumor necrosis factor alpha (TNFα, P = 
0.0001). 
Levine et al., 
2018 (74) 
Cross-
sectional 
Women’s Health Initiative 
Study (WHI), 
Framingham Heart Study 
(FHS), Normative Aging 
Study (NAS), Jackson 
Heart Study (JHS) 
9,164 DNAm 
PhenoAge 
Whole 
blood 
Coronary heart 
disease 
Higher DNAm PhenoAge associated with 
increased risk of coronary heart disease (β = 
0.016- 0.073; P = 3.35E-11). 
Levine et al., 
2018 (74) 
Cross-
sectional 
Religious Order Study 
(ROS), Memory and 
Aging Project (MAP) 
700 DNAm 
PhenoAge 
Dorsolateral 
prefrontal 
cortex 
postmortem 
samples 
Alzheimer’s 
disease 
DNAm PhenoAge positively associated with 
neuropathological hallmarks of Alzheimer’s 
disease, such as amyloid load (r = 0.094, P = 
0.012), neuritic plaques (r = 0.11, P = 0.0032), 
and neurofibrillary tangles (r = 0.10, P = 
0.0073). 
Levine et al., 
2018 (74) 
Cross-
sectional 
Women’s Health Initiative 
(WHI) Study  
4,177 DNAm 
PhenoAge 
Whole 
Blood 
Blood pressure Positive association between PhenoAge and 
systolic BP (r = 0.08, P = 1E-6). 
Lu et al., 2019 Cross-
sectional 
Framingham Heart Study 
(FHS), Women’s Health 
Initiative (WHI) study, the 
InCHIANTI cohort study, 
7,375 AgeAccelGrim Whole 
blood 
Time-to-
death/coronary 
heart 
disease/cancer 
AgeAccelGrim strongly associated with time‐
to‐death (HR = 1.10, P = 2.0E‐ 75), time‐to‐
coronary heart disease (HR = 1.07, P = 6.2E‐
24), time‐to‐cancer (HR = 1.07, P = 1.3E‐12) 
and hypertension (OR = 1.04, P = 5.1E-13). 
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Jackson Heart Study 
(JHS) 
McCrory et 
al., 2019 (112) 
Cross-
sectional 
The Irish Longitudinal 
Study on Ageing (TILDA) 
cohort 
490 Horvath EAA Buffy coat Allostatic load 
(AL) 
AL not significantly associated with EAA (β= 
0.11, CI: −0.16, 0.38, P > 0.05). 
McCrory et 
al., 2019 (112) 
Cross-
sectional 
The Irish Longitudinal 
Study on Ageing (TILDA) 
cohort 
490 Hannum EAA Buffy coat Allostatic load AL not significantly associated with EAA (β= 
0.06, CI: −0.21, 0.33, P < 0.05). 
McCrory et 
al., 2019 (112) 
Cross-
sectional 
The Irish Longitudinal 
Study on Ageing (TILDA) 
cohort 
490 Levine EAA Buffy coat Allostatic load AL significantly associated with Levine EAA 
(β= 0.42, CI: 0.24, 0.60, P < 0.001). 
Quach et al., 
2017 (58) 
Cross-
sectional 
Women’s Health Initiative 
study/ InCHIANTI study 
4,575 EEAA Whole 
blood 
Blood pressure EEAA significantly associated with systolic 
BP (r = 0.07, P = 4E-6). 
Vetter et al., 
2019 (113) 
Cross-
sectional 
Berlin Aging Study II 1,790 IEAA Whole 
blood 
Telomere 
length 
rLTL is inversely associated with DNAm age 
acceleration (β = −0.002, P = 0.007). 
 
Case-control studies 
Horvath 
&Ritz, 2015 
Case-control The Parkinson's disease, 
Environment & Genes 
(PEG) study 
592 EEAA Blood Parkinson’s 
disease (PD) 
PD status positively associated with EEAA (P 
= 0.0061). 
Horvath 
&Ritz, 2015 
(73) 
Case-control The Parkinson's disease, 
Environment & Genes 
(PEG) study 
592 Horvath Age 
Accel 
 
Blood Parkinson’s 
disease (PD) 
PD status positively associated with Horvath 
age acceleration (P = 0.06). 
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Horvath 
&Ritz, 2015 
(73) 
Case-control The Parkinson's disease, 
Environment & Genes 
(PEG) study 
592 IEAA Blood Parkinson’s 
disease (PD) 
PD status positively associated with IEAA (P 
= 0.019). 
Perna et al., 
2016 (85) 
Case-cohort 
study 
ESTHER cohort 1,864 Horvath 
AgeAccel 
Whole 
blood 
CVD, cancer AgeAccel associated with CVD mortality (HR 
= 1.20; 95% CI: 1.02–1.42), and cancer 
mortality (HR = 1.20; 95% CI: 1.03–1.39). 
AL, allostatic load; BP, blood pressure; CRP, C-reactive protein; CVD, cardiovascular disease; EAA, epigenetic age acceleration; EEAA, extrinsic epigenetic age 
acceleration; HDL, high-density; IEAA, intrinsic epigenetic age acceleration; lipoprotein; HR, hazard ratio; PD, Parkinson’s disease; rLTL, relative leukocyte telomere 
length; TNFα, tumor necrosis factor alpha 
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Table 4: 
Studies investigating dietary factors and epigenetic age or epigenetic age acceleration 
Study Study design Population  Dietary factor  Sample 
size (n) 
Age estimator Source of 
DNA  
Effect 
 
Randomized trials and intervention studies 
Chen et al., 
2019 (114) 
Randomized 
clinical trial 
Overweight/obese 
African Americans 
Vitamin D3 51 Horvath 
DNAm age 
Buffy coat Supplementation with 4000 IU/day vitamin D3 
associated with 1.85 years decrease in Horvath 
epigenetic age compared with placebo (P = 
0.046). 
       Serum 25(OH)D concentrations significantly 
associated with decreased Horvath ∆Age (P = 
0.002), independent of treatment. 
Chen et al., 
2019 (114) 
Randomized 
clinical trial 
Overweight/obese 
African Americans 
Vitamin D3 51 Hannum 
DNAm age 
Buffy coat Supplementation with 2000 IU/day vitamin D3 
associated with 1.90 years decrease in Hannum 
epigenetic age (P = 0.044). 
Sae-Lee et al., 
2018 (87) 
Randomized 
controlled trial 
B-vitamins for the 
Prevention of 
Osteoporotic 
Fractures (B-
PROOF) study 
Folic acid, 
vitamin B12 
44 Horvath Age 
Accel 
Buffy coat Reduced age acceleration in response to folic 
acid and vitamin B-12 supplementation in 
women with MTHFR 677CC genotype (P = 
0.04). 
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Sae-Lee et al., 
2018 (87) 
Intervention 
study 
Non-obese healthy 
male smokers 
Monomeric and 
oligomeric 
flavanol 
13 Horvath Age 
Accel 
Leukocytes No change in age acceleration in response to 
monomeric and oligomeric flavanol (MOF) 
supplementation. 
Cross-sectional studies 
Levine et al., 
2018 (74) 
Cross-sectional Women’s Health 
Initiative (WHI) 
study 
Carotenoids 2,267 PhenoAge 
Accel 
Whole 
blood 
Lower PhenoAgeAccel associated with increased 
mean intake of carotenoids (r = -0.22, P = 2xE-
27), lycopene (r = -0.11, P = 3E-3), alpha-
carotene (r = -0.19, P = 5E-20), beta-carotene (r 
= -0.18, P = 2E-17), lutein + zeaxanthin (r = -
0.17, P = 2E-16), beta-cryptoxanthin (r = -0.17, 
P = 2E-15) but positively associated with 
gamma-tocopherol (r = 0.07, P = 6E-4). 
Lu et al., 
2019 (75) 
Cross-sectional Framingham Heart 
Study (FHS) 
Omega-3 
polyunsaturated 
fatty acids 
2174 AgeAccelGrim Whole 
blood 
Omega-3 polyunsaturated fatty acids and 
vegetable intake associated with lower GrimAge 
(r = -0.10, P = 4.6E-7, linear mixed effects P = 
1.3E-5). Effect more pronounced in males (r=-
0.08, P = 0.012) than in females (r = -0.05, P = 
0.07). 
Quach et al., 
2017 (58) 
Cross-sectional Women’s Health 
Initiative 
study/InCHIANTI 
study 
Carotenoids 
 
 
 
 
4,575 EEAA Whole 
blood 
Lower EEAA significantly associated with 
higher mean plasma carotenoid levels (r = -0.13, 
P = 2E-9), alpha-carotene (r = -0.11, P = 9E-8), 
beta- carotene (r = -0.11, P = 3E-7), lutein + 
zeaxanthin (r = -0.9, P = 1E-5), beta-
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 cryptoxanthin (r = -0.11, P = 3E-7) and lower 
gamma-tocopherol (r = 0.09, P = 9E-6). 
   Fish    Lower EEAA associated with higher intake of 
fish (tmeta = -2.92, pmeta = 0.003). 
Quach et al., 
2017 (58) 
Cross-sectional Women’s health 
Initiative study/ 
InCHIANTI study 
Tocopherol 4,575 IEAA Whole 
blood 
Lower IEAA associated with lower plasma 
gamma-tocopherol (r = 0.08, P = 2E-4). 
EEAA, extrinsic epigenetic age, IEAA, intrinsic epigenetic age 
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Figure 1 
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Figure 2 
 
 
  
 
 
